Cargando…

Mechanisms of SARS-CoV-2-induced Encephalopathy and Encephalitis in COVID-19 Cases

The SARS-CoV-2 virus caused an unprecedented pandemic around the globe, infecting 36.5 million people and causing the death of over 1 million in the United States of America alone. COVID-19 patients demonstrated respiratory symptoms, cardiovascular complications, and neurologic symptoms, which in mo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vengalil, Aaron, Nizamutdinov, Damir, Su, Matthew, Huang, Jason H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Complications of COVID-19 on Brain Health
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225804/ https://www.ncbi.nlm.nih.gov/pubmed/37255742 http://dx.doi.org/10.1177/26331055231172522

Ejemplares similares

SARS-CoV-2 and Hypertension: Evidence Supporting Invasion into the Brain Via Baroreflex Circuitry and the Role of Imbalanced Renin-Angiotensin-Aldosterone-System
por: Oliveira, Kellysson Bruno, et al.
Publicado: (2023)

Acute necrotizing encephalopathy due to SARS-CoV-2 in a pregnant female
por: Breit, Hannah, et al.
Publicado: (2021)

Posterior reversible encephalopathy syndrome: an atypical neurological manifestation of SARS-CoV-2 infection
por: Gasparotto, Michela, et al.
Publicado: (2022)

Autoimmune encephalitis following ChAdOx1-S SARS-CoV-2 vaccination
por: Kwon, Hyeryung, et al.
Publicado: (2021)

Delayed presentation of postinfectious encephalitis associated with SARS-CoV-2 infection: a case report
por: Gunawardhana, Champika, et al.
Publicado: (2021)

Neuromuscular Disorders Associated With COVID-19
por: Morgan, Larry, et al.
Publicado: (2023)

COVID-19 Vaccine Evolution and Beyond
por: Brice, Yardley, et al.
Publicado: (2023)

The Relationship Between COVID-19 and the Development of Depression: Implications on Mental Health
por: Shetty, Padmashri A, et al.
Publicado: (2023)

Chronic Neurocognitive, Neuropsychological, and Pulmonary Symptoms in Outpatient and Inpatient Cohorts After COVID-19 Infection
por: Oliver, Samuel F, et al.
Publicado: (2023)

New-onset refractory status epilepticus (NORSE) in post SARS-CoV-2 autoimmune encephalitis: a case report
por: Dono, Fedele, et al.
Publicado: (2020)

Immune-mediated neurological syndrome in SARS-CoV-2 infection: a review of literature on autoimmune encephalitis in COVID-19
por: Payus, Alvin Oliver, et al.
Publicado: (2021)

Neurological Complications of SARS-CoV, MERS-CoV, and COVID-19
por: Alshebri, Munirah Saad, et al.
Publicado: (2020)

Air filtration and SARS-CoV-2
por: Nazarenko, Yevgen
Publicado: (2020)

Infections sévères à SARS-CoV-2
por: Taghboulit, N., et al.
Publicado: (2021)

Association between stopping universal SARS-CoV-2 admission testing and hospital-onset SARS-CoV-2 in England and Scotland
por: Pak, Theodore, et al.
Publicado: (2023)

The OM-85 bacterial lysate inhibits SARS-CoV-2 infection of epithelial cells by downregulating SARS-CoV-2 receptor expression
por: Pivniouk, Vadim, et al.
Publicado: (2022)

The utility of SARS‐CoV‐2‐specific serology in COVID‐19 diagnosis
por: Hasan, Tasnim, et al.
Publicado: (2021)

The SARS-CoV-2 Outbreak: an Epidemiological and Clinical Perspective
por: Wong, Rebecca S. Y.
Publicado: (2020)

Diaphragmatic myoclonus due to SARS-CoV-2 infection
por: Borroni, Barbara, et al.
Publicado: (2020)

SARS-CoV-2, an Underestimated Pathogen of the Nervous System
por: Jakhmola, Shweta, et al.
Publicado: (2020)

SARS-CoV-2 vaccine-related neurological complications
por: Oonk, Nicol G. M., et al.
Publicado: (2022)

A Cluster of Aspergillosis Associated with SARS-CoV-2
por: VerLee, Kerrie, et al.
Publicado: (2021)

Mitigation Strategies to Reduce Aerosolization of SARS-CoV-2
Publicado: (2022)

The arrival of SARS-CoV-2–neutralizing antibodies in a currently available commercial immunoglobulin
por: Miller, Aaron L., et al.
Publicado: (2022)

The role of IL-6 and other mediators in the cytokine storm associated with SARS-CoV-2 infection
por: Copaescu, Ana, et al.
Publicado: (2020)

The Evidence for High-Titer Convalescent Plasma in SARS-CoV-2
por: Fisher, David L., et al.
Publicado: (2021)

Nationwide seroprevalence of antibodies against SARS-CoV-2 in Israel
por: Reicher, Shay, et al.
Publicado: (2021)

Broken Heart (Takotsubo) Syndrome Triggered by SARS-CoV-2
por: Finsterer, Josef
Publicado: (2021)

Asthma and viruses: A focus on rhinoviruses and SARS-CoV-2
por: Padayachee, Yorissa, et al.
Publicado: (2021)

Seroepidemiology of SARS-CoV-2, Yamagata, Japan, June 2020
por: Morikane, Keita, et al.
Publicado: (2021)

Cognitive phenotyping of post-infectious SARS-CoV-2 patients
por: Aiello, Edoardo Nicolò, et al.
Publicado: (2022)

The Association of Cardiovascular Diseases and Diabetes Mellitus with COVID-19 (SARS-CoV-2) and Their Possible Mechanisms
por: Roy, Sourav, et al.
Publicado: (2020)

Animal Models to Study Emerging Technologies Against SARS-CoV-2
por: Mullick, Jhinuk Basu, et al.
Publicado: (2020)

Protective Effects of CVD and DM Medications in SARS-CoV-2 Infection
por: Bangi, Shifa, et al.
Publicado: (2020)

SARS-CoV-2-Related Kidney Injury: Current Concern and Challenges
por: Cheng, Yongqian, et al.
Publicado: (2020)

Important Steps to Control COVID-19/SARS-CoV-2 Infection
por: Chatterjee, Sudipto
Publicado: (2020)

First motor seizure as presenting symptom of SARS-CoV-2 infection
por: Fasano, Antonio, et al.
Publicado: (2020)

Potential neurological impact of coronaviruses: implications for the novel SARS-CoV-2
por: Iroegbu, Joy D., et al.
Publicado: (2020)

Reversible conduction block of peroneal nerve associated with SARS-CoV-2
por: Cioffi, Ettore, et al.
Publicado: (2021)

Prevalence of SARS-CoV-2 Antibody in Healthcare Workers in Central Pennsylvania
por: Kwon, Taesung, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_debrlku0o1k59rnepl5ai92epj